Screening, prevention and treatment of cervical cancer—A global and regional generalized cost-effectiveness analysis

This publication has 40 references indexed in Scilit:

• Cervical cancer as a priority for prevention in different world regions: An evaluation using years of life lost
  International Journal of Cancer, 2004
• A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV‐16/18 vaccine
  International Journal of Cancer, 2003
• COST-EFFECTIVENESS ANALYSIS: CAN WE REDUCE VARIABILITY IN COSTING METHODS?
  International Journal of Technology Assessment in Health Care, 2003
• Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk
  The Lancet, 2003
• Programme costs in the economic evaluation of health interventions
  Cost Effectiveness and Resource Allocation, 2003
• Cost-effectiveness of Alternative Triage Strategies for Atypical Squamous Cells of Undetermined Significance
  JAMA, 2002
• Policy Analysis of Cervical Cancer Screening Strategies in Low-Resource Settings
  JAMA, 2001
• Development of WHO guidelines on generalized cost-effectiveness analysis
  Health Economics, 2000
• Screening for cervical cancer: different problems in the developing and the developed world
  European Journal of Cancer Care, 1997
• International incidence rates of invasive cervical cancer after introduction of cytological screening
  Cancer Causes & Control, 1997